← FDA Drug Approvals (Drugs@FDA)

DACTINOMYCIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MEITHEAL · Approved 2020-11-13

Drug application

FDA Application #

ANDA213463

Application type

Abbreviated New Drug Application (Generic)

Brand name

DACTINOMYCIN

Generic name

DACTINOMYCIN

Active ingredients

DACTINOMYCIN

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

MEITHEAL

Manufacturer

Meitheal Pharmaceuticals Inc.

First approval

2020-11-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown